Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086185 · ClinicalTrials.gov registry record
Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients
A clinical trial, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- 7
- Enrollment target
NCT05086185 is a clinical trial that has completed, run by University of Nevada, Reno. The registered enrollment target is 7 participants.
The verdict
NCT05086185 has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
High blood potassium levels (hyperkalemia) is a major problem for people with kidney failure undergoing hemodialysis treatment. In order to reduce the risk of hyperkalemia, people with kidney failure are advised to limit or avoid high-potassium foods. However, high-potassium foods comprise many healthy food choices, including commonly consumed fruits and vegetables that are key sources of dietary fiber, and other important nutrients. Risk of hyperkalemia from dietary potassium intake is most notable in the first few hours after a meal when ingested potassium enters the bloodstream. In general, dietary potassium is very well absorbed. However, dietary fiber has been shown to increase the proportion of dietary potassium that is excreted in stool. Based on these findings, it has been proposed that fiber may help to lower the risk of hyperkalemia in people with kidney disease. It remains unclear whether dietary fiber increases potassium excretion in stool by reducing the absorption of dietary potassium, or by drawing body potassium into the bowels by increasing stool bulk. The distinction may be important, as reducing potassium absorption would be expected to be of greater benefit in preventing hyperkalemia caused by eating high-potassium foods. In this study, the investigators will assess whether a fiber supplement can reduce the effect of dietary potassium from orange juice on blood potassium levels in people with kidney disease undergoing maintenance hemodialysis treatment.
Interventions
- DIAGNOSTIC_TEST Kalemic Response to Orange Juice
- DIETARY_SUPPLEMENT Kalemic Response to Orange Juice with Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-10-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05086185
The ClinicalTrials.gov registry entry for NCT05086185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Reno, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Kalemic Response to Orange Juice is the first listed.
NCT05086185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05086185 about?
NCT05086185 is a clinical study titled "Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients". High blood potassium levels (hyperkalemia) is a major problem for people with kidney failure undergoing hemodialysis treatment. In order to reduce the risk of hyperkalemia, people with kidney failure are advised to limit or avoid high-potassium foods. However, high-potassium foods comprise many heal...
What is the current status of trial NCT05086185?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2021-06-29. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT05086185?
The interventions under investigation include: Kalemic Response to Orange Juice (DIAGNOSTIC_TEST), Kalemic Response to Orange Juice with Fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05086185?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.